Tag: immuno-oncology
10x Genomics introduces new solutions for single cell and spatial biology research
10x Genomics, Inc. (Nasdaq: TXG), a pioneering company in single cell and spatial biology, has announced the commercial release of its Xenium multi-modal cell segmentation ... Read More
FDA approves BeiGene’s TEVIMBRA for esophageal cancer treatment
In a notable advancement in the oncology sector, BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a globally recognized oncology company, has received approval from ... Read More